Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid

Clinical Cancer Research

Volumn 2, Issue 12, 1996, Pages 1931-1935

  Yung, W K Alfred ^a   Kyritsis, Athanassios P ^a   Gleason, Mary Jo ^a   Levin, Victor A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLIOMA; HUMAN; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; ISOTRETINOIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030444288     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kornblith, P. L., and Walker, M. Chemotherapy for malignant gliomas. J. Neurosurg., 68: 1-17, 1988.
2. Walker, M. D., Alexander, E., Jr., Hunt, W. E., Leventhal, C. M., Mahaley, M. S., Jr., Mealey, J., Norrell, H. A , Owen, G., Ransohoff, J., Wilson, C. B., and Gehan, E. A. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg., 49: 333, 1978.
3. Levin, V. A., Silver, P., Hannigan, J., Wara, W. M., Gutin, P. H., Davis, R. L.-, and Wilson, C. B. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int. J. Radiat. Oncol. Biol. Phys., 18: 321-324, 1990.
4. Yung, W. K. A. Chemotherapy for malignant brain tumors. Curr. Opin. Oncol., 2: 673-678, 1990.
5. Tapazoglou, E., Kish, J., and Ensley, J. Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. Am. J. Clin. Oncol., 11: 474-478, 1988.
6. Yung, W. K. A., Harris, M. I., Bruner, J. M., and Feun, L. G. Intravenous BCNU and AZQ in patients with recurrent malignant gliomas. J. Neuro-oncol., 7: 237-240, 1989.
7. Yung, W. K. A., Mechtler, L. M., and Gleason, M. J. Intravenous carboplatin for recurrent malignant gliomas: a phase II study. J. Clin. Oncol., 9: 860-864, 1991.
8. Levin, V A., Prados, M. D., Yung, W. K. A., Gleason, M. J., Ictech, S., and Malec, M. Treatment of recurrent gliomas with eflornithine. J. Natl. Cancer Inst., 84: 1432-1437, 1992.
9. Lippman, S. M., and Meyskens, F. L., Jr. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann. Intern. Med., 107: 499-501, 1987.
10. Kessler, J. F., Jones, S. E., Levine, N., Lynch, P. J., Booth, A. R., and Meyskens, F. L., Jr. Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides). Arch. Dermatol., 123: 201-204, 1987.
11. Lippman, S. M., and Meyskens, F. L., Jr. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmacol. & Ther., 40: 107-122, 1989.
12. Lippman, S. M., and Meyskens, F. L. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin Ann. Intern. Med., 107: 499-501, 1987.
13. Lippman, S. M., Kessler, J. F., Al-Sarraf, M., Alberts, D. S., Itri, M., Mattox, D., Von Hoff, D. D., Loescher, L., and Meyskens, F. L. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. Invest. New Drugs, 6, 13-17, 1988
14. Gold, E. J , Mertelsmann, R. H., Itri, L. M., Gee, T , Arlin, Z., Kempin, S., Clarkson, B., and Moore, M. A. Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. Cancer Treat. Rep., 67: 981-986, 1983.
15. Flynn, P. J., Miller, W. J., Weisdorf, D. J., Arthur, D C , Brunning, R., and Branda, R. F. Retinoic acid treatment of acute promyelocytic leukemia: in vitro observations Blood, 62: 1211-1217, 1983.
16. Huang, M., Ye, Y., Chen, S., and Chai, J. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72: 567-572, 1988.
17. Tallman, M. S. All trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies. Semin. Hematol., 5 (Suppl.): 38-48, 1994.
18. Fenaux, P., Chastang, C., Chomienne, C., Castaigne, S., Sanz, M., Link, H., Lowenberg, B., Fey, M., Archimbaud, E. and Degos, L. Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all trans-retinoic acid (ATRA) combined with chemotherapy: the European experience: European APL Group. Leuk. & Lymphoma, 16: 431-437, 1995.
19. Yung, W. K. A., Lotan, D., Lee, R., Lotan, R., and Steck, P. A. Modulation of growth and EGF receptor activity by retinoic acid in human glioma cells. Cancer Res., 49: 1014-1019, 1989.
20. Wong, E. T., Hess, K. R., Gleason, M. J , Jaeckle, K. A., Kyritsis, A. P., Prados, M. D., Levin, V. A., and Yung, W. K. A. Time to tumor progression as a measure of efficacy in phase II chemotherapy trials for recurrent malignant gliomas. Proc. ASCO, 15: 153, 1996.
21. Couldwell, W. T., Hinton, D. R., Surnock, A. A., DeGiorgio, C. M., Weiner, L. P., Apuzzo, M. L. J., Masri, L., Law, R. E., and Weiss, M. H. Treatment of recurrent malignant gliomas with chronic and high-dose tamoxifen. Clin. Cancer Res., 2: 619-622, 1996.
22. Rodriguez, L. A., Prados, M., Silver, P. and Levin, V. A. Reevaluation of procarbazine for the treatment of recurrent malignant CNS tumors. Cancer (Phila.), 64: 2420-2423, 1989.
23. Yung, W K. A., Prados, M., Levin, V. A., Fetell, M. R., Bennett, J. M., Mahaley, M. S., Salcman, M., and Etanbanes, E Intravenous recombinant interferon-β in patients with recurrent malignant gliomas: a phase I/II study. J. Clin. Oncol., 9: 1945-1949, 1991.
24. Huang, M., Ye, Y., Chen, S., Choi, J., Lu, J., Zhoa, L., Gu, L., and Wang, Z. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72: 567-572, 1988.